Literature DB >> 15239911

A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.

Graeme D Smith1, Douglas T Steinke, Moira Kinnear, Kay I Penny, Nim Pathmanathan, Ian D Penman.   

Abstract

BACKGROUND: It is thought that people with irritable bowel syndrome (IBS) who consult secondary care have more severe symptomatology than those treated mainly in primary care. AIMS: To describe the physical and psychological symptoms of IBS, and the health-related quality of life of patients managed in primary and secondary care. DESIGN OF STUDY: Cross-sectional observational survey.
SETTING: The general population of the United Kingdom (UK).
METHODS: A cohort of people with IBS symptoms was recruited via a UK-wide newspaper advertisement. Frequency, duration and severity of symptoms, and health-related quality of life data were collected by semi-structured telephone interviews. Descriptive analysis allowed the comparison of those managed in primary care with those consulting secondary care. Logistic regression was used to identify factors associated with patients consulting secondary care.
RESULTS: Data on 486 participants with confirmed IBS (Rome II criteria) were examined. Similar patterns in symptom severity were found in primary and secondary care groups. Factors associated with IBS patients consulting secondary care were: male sex, a longer length of time since diagnosis, having frequent bowel motions, not having dyspepsia in the past 3 months, and having used medication and alternative therapies. Although patients managed in secondary care have greater impairment to their usual activities, both groups had similar health-related quality-of-life profiles.
CONCLUSION: High levels of physical and psychological morbidity were present in population-based volunteers managed in both primary and secondary care. This study suggests that patients with IBS managed solely in primary care are affected as much as those attending secondary care.

Entities:  

Mesh:

Year:  2004        PMID: 15239911      PMCID: PMC1324801     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  14 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

2.  Symptomatology, quality of life and economic features of irritable bowel syndrome--the effect of hypnotherapy.

Authors:  L A Houghton; D J Heyman; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1996-02       Impact factor: 8.171

3.  Health-related quality of life among persons with irritable bowel syndrome: a systematic review.

Authors:  H B El-Serag; K Olden; D Bjorkman
Journal:  Aliment Pharmacol Ther       Date:  2002-06       Impact factor: 8.171

Review 4.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

5.  Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials.

Authors:  G F Longstreth; C J Hawkey; E A Mayer; R H Jones; J Naesdal; I K Wilson; R A Peacock; I K Wiklund
Journal:  Aliment Pharmacol Ther       Date:  2001-07       Impact factor: 8.171

6.  Irritable bowel syndrome in general practice: prevalence, characteristics, and referral.

Authors:  W G Thompson; K W Heaton; G T Smyth; C Smyth
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

7.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.

Authors:  Fermín Mearin; Agustín Balboa; Xavier Badía; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Montse Roset; Nicholas J Talley
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 2.566

Review 9.  Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials.

Authors:  N J Talley; B K Owen; P Boyce; K Paterson
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

10.  Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization.

Authors:  N J Talley; A R Zinsmeister; L J Melton
Journal:  Am J Epidemiol       Date:  1995-07-01       Impact factor: 4.897

View more
  12 in total

1.  Irritable bowel syndrome: management of expectations and disease.

Authors:  Roger Jones
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Authors:  Massimo Bellini; Cesare Tosetti; Francesco Rettura; Riccardo Morganti; Christian Lambiase; Gabrio Bassotti; Pierfrancesco Visaggi; Andrea Pancetti; Edoardo Benedetto; Nicola de Bortoli; Paolo Usai-Satta; Rudi De Bastiani
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

Review 4.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

5.  Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt.

Authors:  Ahmed Abdulmajeed; Mohamed A Rabab; Hamdy A Sliem; Nour Eldein Hebatallah
Journal:  Pan Afr Med J       Date:  2011-05-18

6.  Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

7.  Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study.

Authors:  Raika Jamali; Mostafa Raisi; Mohammad Matini; Alireza Moravveji; Abdollah Omidi; Jaleh Amini
Journal:  Adv Biomed Res       Date:  2015-03-25

8.  A protocol for a trial of homeopathic treatment for irritable bowel syndrome.

Authors:  Emily J Peckham; Clare Relton; Jackie Raw; Clare Walters; Kate Thomas; Christine Smith
Journal:  BMC Complement Altern Med       Date:  2012-11-06       Impact factor: 3.659

9.  Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981

10.  Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.

Authors:  Carla E Flik; Wijnand Laan; André J P M Smout; Bas L A M Weusten; Niek J de Wit
Journal:  BMC Gastroenterol       Date:  2015-11-26       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.